REGN

Regeneron Pharmaceuticals, Inc.

Halal Rating :
Uncomfortable
See Details
Last Price $957.51 Last updated:
Market Cap $98.34b
7D Change 8.41%
1 Year Change 27.01%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 2, 2024

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $3.42b $2.99b $148.7m $18.3m 4.35% 0.61%
Sept. 30, 2023 $3.34b $2.37b $133.7m $17.8m 4.00% 0.75%
June 30, 2023 $3.14b $2.41b $118.3m $18.9m 3.77% 0.78%

Company Impact

Help us evaluate Regeneron Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates